Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-29

Clinical Trial Update: Dextromethorphan, Memantine Monotherapy, or Combined Use of Dextromethorphan and Memantine in Amphetamine Addiction [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating dextromethorphan, memantine monotherapy, or their combination for amphetamine addiction is ongoing; current status is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextromethorphan (dextromethorphan)
  • Memantine (memantine)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Amphetamine Addiction, Pharmacotherapy | Phase 2, Phase 3 | Status: UNKNOWN